当前位置: X-MOL 学术Lancet Global Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Research misconduct and the INTERGROWTH-21st study
The Lancet Global Health ( IF 34.3 ) Pub Date : 2017-08-22 , DOI: 10.1016/s2214-109x(17)30336-4
Lawrence D Platt , Torvid Kiserud , Marshall Lindheimer

We respectfully take issue with the Comment published in February, 2017, by members of The Lancet's editorial staff stating that WHO's judgment of misconduct regarding the Oxford INTERGROWTH-21st study was unproven.1–3 We are saddened by the fact that they base their conclusion on limited and biased material and simply dismiss the case as rivalry. As members of the WHO Fetal Growth research group and a former WHO external expert not associated with that trial but with evidence that WHO initially refused to hear, we wish to note the following.

中文翻译:

研究不端行为和INTERGROWTH-21st研究

我们尊重《柳叶刀》杂志编辑人员于2017年2月发表的《评论》,指出世卫组织对牛津INTERGROWTH-21st研究的不当行为的判断未经证实。1-3我们为他们的结论基于有限和有偏见的材料而简单地将案件视为竞争而感到遗憾。作为世卫组织胎儿生长研究小组的成员以及与该试验无关的前世卫组织外部专家,但有证据表明世卫组织最初拒绝听证,我们谨指出以下几点。
更新日期:2017-08-23
down
wechat
bug